🔍 Key Findings
- Overall complication rate was 19.7% (43/218), with most being mild (CSS 1).
- Soft tissue procedures had higher complication rates (26%) than orthopedic procedures (11.6%) (P < 0.01).
- No difference in complication rates between clean, clean-contaminated, and contaminated wounds (P = 0.55).
- No difference in complication rates between labeled use (CCL surgery) and off-label orthopedic procedures (P = 0.21).
- Majority of complications (63%) were mild, resolving without intervention or with topical therapy.
- Severe complications requiring revision surgery were rare (2.3%) and occurred mainly in soft-tissue surgeries.
- Most common complications included SSI (25.6%), dehiscence (16.3%), and seroma (14%).
- Liposomal bupivacaine appears safe for use in broader orthopedic procedures beyond current labeling.

